Information  X 
Enter a valid email address

Kromek Group PLC (KMK)

  Print      Mail a friend

Monday 12 June, 2017

Kromek Group PLC

Kromek Radiation Detectors Used During Trump Visit

RNS Number : 7432H
Kromek Group PLC
12 June 2017


12 June 2017


Kromek Group plc

("Kromek" or the "Company")


Kromek's Radiation Detectors Used by the European Commission Counter Terrorism Unit During President Trump's Visit to Brussels


Kromek (AIM: KMK), a radiation detection technology company focusing on the medical, security screening and nuclear markets, is pleased to announce that its next generation standalone radiation detector, D3S-ID, was deployed by European Commission Counter Terrorism Unit of Directorate General for Home Affairs in Brussels. The D3S-ID was part of security operations deployed during the NATO Security Summit and the U.S. President, Donald Trump's visit to Brussels last month.


The European Commission and Belgian Federal Police officers deployed D3S-ID at different locations including Brussels airport and the European Council headquarters.  Kromek was informed that the deployment was successful and its radiation detection systems performed well and met the desired high standards for accuracy and efficiency.


Dr Arnab Basu, Chief Executive Officer of Kromek, said: "We are delighted to be part of the security system that was deployed during President Trump's visit to Brussels. Specifically, we were pleased that the deployment was successful and that our detectors achieved the necessary high standards. We look forward to continuing our work with the European Commission, DARPA and other national law enforcement agencies to deploy our best-of-breed radiation detectors to protect people and property."



01740 626 060

Arnab Basu, CEO

Derek Bulmer, CFO

020 7397 8900

Bobbie Hilliam (NOMAD)

Harry Pardoe

020 7618 9100

Harry Chathli, Claire Norbury, Alexis Gore



About Kromek Group plc


Kromek Group plc is a UK technology Group (global HQ in County Durham) and a leading developer of high performance radiation detection products based on cadmium zinc telluride ("CZT") and other advanced technologies. Using its core technology platforms, Kromek designs, develops and produces x-ray and gamma photon imaging and radiation detection products for the medical, security screening and nuclear markets.


The Group's products provide high resolution information on material composition and structure and are used in multiple applications, ranging from the identification of cancerous tissues to hazardous materials, such as explosives, and the analysis of radioactive materials.


The Group's business model provides a vertically integrated technology offering to customers, from radiation detector materials to finished products or detectors, including software, electronics and application specific integrated circuits ("ASICs").


The Group has operations in the UK and US (California and Pennsylvania), and is selling internationally through a combination of distributors and direct OEM sales.


Currently, the Group has over one hundred full time employees across its global operations. Further information on Kromek Group is available at and



This information is provided by RNS
The company news service from the London Stock Exchange

a d v e r t i s e m e n t